Gilead Sciences’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$256M Hold
31,424,760
19.98% 3
2025
Q1
$247M Buy
31,424,760
+1,363,636
+5% +$10.7M 20.88% 3
2024
Q4
$448M Buy
+30,061,124
New +$448M 28.86% 3